Author

Kazuaki Shinoda

Observed names: K. Shinoda, 和明篠田, 篠田和明

Observed institution: Yokohama City University

OpenAlex ID: A5070542138

Ezetimibe decreases SREBP-1c expression in liver and reverses hepatic insulin resistance in mice fed a high-fat diet

2010 · Tomonori Muraoka, Kazutaka Aoki, et al. · Metabolism · 64

Efficacy and Safety of Ipragliflozin in Japanese Patients With Type 2 Diabetes: Interim Outcome of the ASSIGN-K Study

2015 · Takashi Iizuka, Kotaro Iemitsu, et al. · Journal of Clinical Medicine Research · 40

PDF

Ipragliflozin Improves Glycemic Control and Decreases Body Fat in Patients With Type 2 Diabetes Mellitus

2017 · Takehiro Kawata, Takashi Iizuka, et al. · Journal of Clinical Medicine Research · 24

PDF

Impact of the Dipeptidyl Peptidase-4 Inhibitor Vildagliptin on Glucose Tolerance and β-Cell Function and Mass in Insulin Receptor Substrate-2-Knockout Mice Fed a High-Fat Diet

2012 · Koichiro Sato, Akinobu Nakamura, et al. · Endocrinology · 20

Effect of liraglutide on lipids in patients with type 2 diabetes: a pilot study

2020 · Kazutaka Aoki, Hiroshi Kamiyama, et al. · Endocrine Journal · 16

PDF

Comparison of pre‐ vs. postmeal administration of miglitol for 3 months in type 2 diabetic patients

2008 · K. Aoki, S. Nakajima, et al. · Diabetes Obesity and Metabolism · 13

Comparison of pre- versus post-meal administration of voglibose in men with or without impaired glucose tolerance

2008 · Kazutaka Aoki, Yuzuru Ito, et al. · Diabetes Research and Clinical Practice · 12

Evaluation of organ-specific glucose metabolism by 18F-FDG in insulin receptor substrate-1 (IRS-1) knockout mice as a model of insulin resistance

2011 · Chao Cheng, Akinobu Nakamura, et al. · Annals of Nuclear Medicine · 9

Comparison of the administration of teneligliptin every day versus every other day in Japanese patients with type 2 diabetes: A randomized non-inferior test

2014 · Kazunari Kamiko, Kazutaka Aoki, et al. · The Journal of Clinical Pharmacology · 6

Glycemic control after addition of the dipeptidyl peptidase-4 inhibitor alogliptin in patients with type 2 diabetes showing inadequate response to thrice-a-day treatment with α-glucosidase inhibitors

2013 · Kiyomi Masuda, Kazutaka Aoki, et al. · Expert Opinion on Pharmacotherapy · 6

Self-Injection of Insulin Using Appropriate Supportive Devices in Handicapped Subjects with Diabetes

2010 · Kiyomi Masuda, Kazutaka Aoki, et al. · Diabetes Technology & Therapeutics · 6

Effects of ipragliflozin on the development and progression of kidney disease in patients with type 2 diabetes: An analysis from a multicenter prospective intervention study

2020 · Ikuro Matsuba, Takehiro Kawata, et al. · Journal of Diabetes Investigation · 5

PDF

Efficacy and Safety of Ipragliflozin in Patients With Type 2 Diabetes: ASSIGN-K Study

2019 · Kotaro Iemitsu, Takehiro Kawata, et al. · Journal of Endocrinology and Metabolism · 4

PDF

Effectiveness of Ipragliflozin for Reducing Hemoglobin A1c in Patients With a Shorter Type 2 Diabetes Duration: Interim Report of the ASSIGN-K Study

2017 · Kotaro Iemitsu, Takehiro Kawata, et al. · Journal of Clinical Medicine Research · 4

PDF

Effect of Switching from Sulphonylurea to Repaglinide Twice or Three Times Daily for 4 Months on Glycemic Control in Japanese Patients with Type 2 Diabetes

2016 · Hiroshi Kamiyama, Kazutaka Aoki, et al. · Internal Medicine · 4

PDF

Effect of repaglinide, administered two or three times daily for 3 months, on glycaemic control in Japanese patients with type 2 diabetes mellitus

2014 · Hiroshi Kamiyama, Kazutaka Aoki, et al. · Journal of International Medical Research · 2

Correction: Efficacy and Safety of Ipragliflozin in Japanese Patients With Type 2 Diabetes: Interim Outcome of the ASSIGN-K Study

2016 · Takashi Iizuka, Kotaro Iemitsu, et al. · Journal of Clinical Medicine Research · 1

PDF

2型糖尿病患者2000人におけるdtr-qolとpaid,血糖コントロールとの関連の検討

2016 · 高橋謙一郎, 山川正, et al. · Tōnyōbyō/Tounyoubyou

糖尿病を伴う高血圧患者に対して (特集 Arbの選び方・使い方)

2009 · 和明篠田, 康夫寺内 · 呼吸と循環

Works count: 19

Citation count: 236

H-index: 8

I10-index: 7